| Title |
Author |
Type |
Date |
Words |
| Strategic consulting, design and implementation of an information and awareness campaign for the recruitment of participants in anti-HIV vaccine trials conducted by the Vaccine Research Institute. |
|
|
May 15, 2013 |
101 |
| AbbVie's Investigational HCV Regimen Receives Breakthrough Therapy Designation from the U.S. Food and Drug Administration. |
|
|
May 6, 2013 |
1504 |
| AbbVie's Investigational HCV Regimen Receives Breakthrough Therapy Designation from the U.S. Food and Drug Administration. |
|
|
May 6, 2013 |
1569 |
| Potential novel treatment for influenza found. |
|
|
May 2, 2013 |
282 |
| Potential Novel Treatment for Influenza Discovered. |
|
|
May 2, 2013 |
506 |
| Risk of nevirapine-associated Stevens-Johnson syndrome among HIV-infected pregnant women: the Medunsa National Pharmacovigilance Centre, 2007-2012. |
Dube, N.; Adewusi, E.; Summers, R. |
|
May 1, 2013 |
3089 |
| Antivirals for systemic use. |
|
|
Apr 26, 2013 |
141 |
| Inhibikase Therapeutics to present at 5th International Congress on Polyomaviruses and Human Diseases. |
|
|
Apr 25, 2013 |
800 |
| Anti-HIV therapy appears to protect children's hearts, NIH network study shows. |
|
|
Apr 22, 2013 |
107 |
| HIV may increase heart attack risk. |
Seppa, Nathan |
Brief article |
Apr 20, 2013 |
162 |
| Frost & Sullivan: New Drug Candidates Hold Tremendous Promise for European HIV Drugs Market. |
|
|
Apr 17, 2013 |
726 |
| Frost & Sullivan: New Drug Candidates Hold Tremendous Promise for European HIV Drugs Market. |
|
|
Apr 17, 2013 |
721 |
| Dolutegravir (HIV) - Forecast and Market Analysis to 2022. |
|
|
Apr 16, 2013 |
1345 |
| Elvitegravir (HIV) - Forecast and Market Analysis to 2022. |
|
|
Apr 16, 2013 |
1341 |
| 572-Trii (HIV) - Forecast and Market Analysis to 2022. |
|
|
Apr 16, 2013 |
1274 |
| Quad 2 (HIV) - Forecast and Market Analysis to 2022. |
|
|
Apr 16, 2013 |
1205 |
| Atripla (HIV) - Forecast and Market Analysis to 2022. |
|
|
Apr 16, 2013 |
1037 |
| Stribild (HIV) - Forecast and Market Analysis to 2022. |
|
|
Apr 11, 2013 |
1066 |
| Cobicistat (HIV) - Forecast and Market Analysis to 2022. |
|
|
Apr 10, 2013 |
1383 |
| Complera (HIV) - Forecast and Market Analysis to 2022. |
|
|
Apr 10, 2013 |
1059 |
| Another Death In China From H7N9 Bird Flu As One Boy Makes Recovery And Anti-Viral Drugs Are Approved. |
|
|
Apr 9, 2013 |
356 |
| HIV eradicated in newborn: only viral traces remain after prompt treatment. |
Seppa, Nathan |
Brief article |
Apr 6, 2013 |
319 |
| Much ado over the new South African PMTCT guidelines. |
Bateman, Chris |
|
Apr 1, 2013 |
2184 |
| Self-testing and home treatment initiation triples uptake of HIV treatment in Malawi. |
Alcorn, Keith |
|
Apr 1, 2013 |
899 |
| Critical AIDS medications: to Africa for the US Government. |
Larson, Chris |
|
Apr 1, 2013 |
1704 |
| Omitting NRTIs may be safe with optimized HIV regimen. |
Wendling, Patrice |
|
Apr 1, 2013 |
806 |
| Chimerix's Antiviral CMX001 Abstract Selected for an Oral Presentation at the European Group for Blood and Marrow Transplantation's Annual Meeting. |
|
|
Mar 28, 2013 |
507 |
| Generics in HIV, a Pharmacoeconomic Reality: How to Manage Change in Europe? |
|
|
Mar 28, 2013 |
782 |
| Research Published in the New England Journal of Medicine Demonstrates Marked and Long-Lasting Antiviral Activity Against HCV for Santaris Pharma A/S' Miravirsen, the First MicroRNA-Targeted Drug to Enter Clinical Trials. |
|
|
Mar 27, 2013 |
1668 |
| Research Published in the New England Journal of Medicine Demonstrates Marked and Long-Lasting Antiviral Activity Against HCV for Santaris Pharma A/S' Miravirsen, the First MicroRNA-Targeted Drug to Enter Clinical Trials. |
|
|
Mar 27, 2013 |
1675 |
| Pain reliever Naproxen may help combat flu. |
|
|
Mar 22, 2013 |
344 |
| PharmaPoint: HIV - China Drug Forecast and Market Analysis to 2022. |
|
|
Mar 20, 2013 |
1546 |
| Funding For AIDS Drugs Not Included In Senate Spending Bill. |
|
|
Mar 19, 2013 |
555 |
| Swine flu virus now resistant to current medicine, Tamiflu. |
|
|
Mar 18, 2013 |
324 |
| Uganda : AIC : With the current allocation and funding, we still have a long way to go ! |
|
|
Mar 16, 2013 |
244 |
| 14 Adults 'Functionally Cured' Of HIV; Can Control Virus Without Drugs. |
|
|
Mar 15, 2013 |
578 |
| FDA Grants Chimerix Fast Track Designation for CMX001 for the Prevention of Clinically Significant Cytomegalovirus Infection. |
|
|
Mar 12, 2013 |
495 |
| Lifelong Antiretroviral Treatment for HIV-Infected Pregnant Women Prevents Infection in Children, Saves Mothers' Lives, Study Finds. |
|
Medical condition overview |
Mar 12, 2013 |
723 |
| Study shows fatty acids could lead to flu drug. |
|
|
Mar 9, 2013 |
256 |
| Ireland - Identification of novel immunomodulators in the human poxvirus molluscum contagiosum virus. |
|
|
Mar 8, 2013 |
334 |
| Chimerix Files Registration Statement for Proposed Initial Public Offering. |
|
|
Mar 8, 2013 |
584 |
| Doctors in the US cure baby of HIV. |
|
|
Mar 7, 2013 |
420 |
| Daily-use HIV prevention strategies prove ineffective among women. |
|
|
Mar 5, 2013 |
662 |
| Doctors in the US cure baby of HIV. |
|
|
Mar 5, 2013 |
420 |
| AHF Demands FDA Reversal on Use of Gilead's HIV Prevention Pill for Women. |
|
|
Mar 5, 2013 |
604 |
| Doctors in the US cure baby of HIV. |
|
|
Mar 4, 2013 |
420 |
| Toddler 'functionally cured' of HIV infection, NIH-supported investigators report. |
|
Brief article |
Mar 4, 2013 |
118 |
| VOICE Trial Results Underscore Need to Accelerate Development of Additional HIV Prevention Options for Women. |
|
|
Mar 4, 2013 |
1218 |
| Coalition of U.S. Women's Health and HIV Advocates Call for Accelerated US Government Plan for Demonstrating Feasibility of PrEP for Women. |
|
|
Mar 4, 2013 |
981 |
| From the executive. |
Conradie, F. |
|
Mar 1, 2013 |
222 |
| Overview of HIV-related lipodystrophy. |
Rossouw, T.M.; Botes, M.E.; Conradie, F. |
|
Mar 1, 2013 |
3749 |
| CPD questionnaire: Vol. 14, No. 1. |
|
|
Mar 1, 2013 |
609 |
| Positive impact of starting antiretrovirals at CD4 count above 500. |
|
|
Mar 1, 2013 |
1785 |
| Fracture risk higher in first 2 years of antiretroviral therapy than in later years. |
|
|
Mar 1, 2013 |
1921 |
| Risky sex and drug injecting drop after drug users start antiretrovirals. |
|
|
Mar 1, 2013 |
1466 |
| CytoDyn Announces Collaboration with Dr. Bruce Torbett, The Scripps Research Institute, to study PRO 140 in a Pre-exposure Prophylaxis (PrEP) Model of HIV Infection. |
|
|
Feb 26, 2013 |
1000 |
| Mylan Launches Innovative Portfolio of Antiretroviral Products for Treatment of HIV/AIDS in South Africa. |
|
|
Feb 23, 2013 |
755 |
| Computer Modeling Reveals How Surprisingly Potent Hepatitis C Drug Works. |
|
|
Feb 19, 2013 |
893 |
| Research and Markets: Nevirapine - Comprehensive 2013 Patent Search. |
|
|
Feb 18, 2013 |
441 |
| Newly identified protein could be used to fight HIV and other deadly viruses. |
|
|
Feb 12, 2013 |
371 |
| Data Related to Chimerix's Antiviral CMX001 to be Presented in Three Poster Sessions at the BMT Tandem Meetings. |
|
|
Feb 4, 2013 |
551 |
| Neurological complications associated with HIV and aids: clinical implications for nursing. |
Theroux, Nicole; Phipps, Meredith; Zimmerman, Lauren; Relf, Michael V. |
Report |
Feb 1, 2013 |
6954 |
| Vitamin D deficiency increases risk of TB among people starting HIV therapy. |
Carter, Michael |
|
Feb 1, 2013 |
892 |
| CBIS Releases Corporate Operational Guidance for 2013 as the Company Reorganizes to better meet the Growing Global Crisis Associated with Anti-Retroviral Drug Resistance among People with AIDS, as well as the Increasing Need for Patient Friendly Skin Cancer Therapies. |
|
|
Jan 31, 2013 |
1708 |
| AHF Challenges Gilead over AIDS Drug Price Gouging of U.S. Gov't Programs on 'Stribild'. |
|
|
Jan 30, 2013 |
600 |
| MDLinx Survey: 22.6 Percent Of US Docs Report Most Patients Ever At This Point In Flu Season. |
|
|
Jan 23, 2013 |
645 |
| Study on Generic HIV Meds Prompts AHF to Demand Gilead Cut ARV Prices. |
|
|
Jan 16, 2013 |
685 |
| Research and Markets: Antiviral Therapeutics - Technologies, Markets and Companies - 2013. |
|
|
Jan 16, 2013 |
463 |
| Abattis receives US and Taiwan trademark approvals for anti-viral brand Defenzall[TM]. |
|
|
Jan 16, 2013 |
306 |
| AHF Blasts Gilead Price Hike on Four Key AIDS Drugs. |
|
|
Jan 10, 2013 |
838 |
| Event 300mg tablet tenofovir 38-2012. In response to amparo 01020-2010-00042. |
|
|
Jan 10, 2013 |
108 |
| Tobira Therapeutics Announces Positive 24-Week Primary Analysis From Phase 2b Trial of Cenicriviroc in Treatment-Naove HIV Infection. |
|
Clinical report |
Jan 7, 2013 |
725 |
| Netherlands : Antiviral Therapy of Viral Hepatitis C. |
|
|
Jan 4, 2013 |
151 |
| FDA Approves Fulyzaq[TM] (Crofelemer) 125 mg Delayed-Release Tablets for the Symptomatic Relief of Diarrhea in Patients with HIV/AIDS on Anti-Retroviral Therapy (ART). |
|
|
Jan 2, 2013 |
1532 |
| USFDA Approves Crofelemer 125 mg Delayed-release Tablets for the Symptomatic Relief of Diarrhea in Patients With HIV/AIDS on Anti-Retroviral Therapy (ART). |
|
|
Jan 2, 2013 |
956 |
| Vibrio vulnificus necrotizing fasciitis preceding herpes zoster. |
Ha, Kelli Y.; Tyring, Stephen K. |
Case study |
Jan 1, 2013 |
1904 |
| Microevolution of highly pathogenic avian influenza A(H5N1) viruses isolated from humans, Egypt, 2007-2011. |
Younan, Mary; Poh, Mee Kian; Elassal, Emad; Davis, Todd; Rivailler, Pierre; Balish, Amanda L.; Simps |
Report |
Jan 1, 2013 |
6048 |
| Protective effect of black seed oil from Nigella sativa against murine cytomegalovirus infection. |
Cumin, Black |
Abstract |
Jan 1, 2013 |
213 |
| AIDS drugs cut SA's maternal death rate. |
Bateman, Chris |
|
Jan 1, 2013 |
376 |
| Putting PrEP into practice: adopt an attitude of discovery: an interview with Robert M. Grant, MD, MPH. |
Mascolini, Mark |
Interview |
Dec 22, 2012 |
3242 |
| Genentech Announces FDA Approval of Tamiflu for the Treatment of Influenza in Infants. |
|
|
Dec 21, 2012 |
821 |
| Sales of Antiretroviral Agents for HIV Will Decline Slightly Over the Next Decade. |
|
|
Dec 17, 2012 |
667 |
| HIV drug 'may help defuse deadly staph infections'. |
|
|
Dec 15, 2012 |
633 |
| FDA Approves Prescribing Information Update for EDURANT (rilpivirine) to Include 96-Week Data in HIV-1-Infected Treatment-Naive Adult Patients. |
|
|
Dec 10, 2012 |
1773 |
| BioCryst Pharmaceuticals Announces Focused Corporate Strategy and Restructuring. |
|
|
Dec 7, 2012 |
1323 |
| Nigeria : MSD offers a new treatment for HIV in NIGERIA. |
|
|
Dec 6, 2012 |
237 |
| AHF: Corporate Welfare Spurs Gilead's Record Profits on AIDS Drugs. |
|
|
Dec 4, 2012 |
643 |
| South Africa : HM announces R5.9-billion tender award in Pretoria for AIDS. |
|
|
Dec 3, 2012 |
160 |
| HE'S ARV DECENT. |
|
|
Dec 3, 2012 |
102 |
| Corrections. |
|
Correction notice |
Dec 1, 2012 |
126 |
| Phased implementation of screening for cryptococcal disease in South Africa. |
Govender, N.P.; Chetty, V.; Roy, M.; Chiller, T.; Oladoyinbo, S.; Maotoe, T.; Stevens, W.S.; Pinini, |
Editorial |
Dec 1, 2012 |
2591 |
| Timing of antiretroviral therapy initiation in adults with HIV-associated tuberculosis: outcomes of therapy in an urban hospital in KwaZulu-Natal. |
Kendon, M.; Knight, S.E.; Ross, A.; Giddy, J. |
Report |
Dec 1, 2012 |
4167 |
| Antiretroviral treatment uptake in patients with HIV-associated TB attending co-located TB and ART services. |
Nglazi, M.D.; Kaplan, R.; Caldwell, J.; Peton, N.; Lawn, S.D.; Wood, R.; Bekker, L.-G. |
Report |
Dec 1, 2012 |
3970 |
| The antiviral activity of Gynostemma pentaphyllum against yellow fever virus. |
Okoye, E.L.; Ezeifeka, G.O.; Esimone, C.O. |
Report |
Dec 1, 2012 |
4651 |
| Mylan Commemorates 24th World AIDS Day. |
|
|
Dec 1, 2012 |
737 |
| Mylan Selected As One of the Leading Suppliers to the South African National Department of Health 2013/2014 Antiretroviral Tender. |
|
|
Nov 29, 2012 |
599 |
| Janssen Announces Intent Not to Enforce Patents for Darunavir in Resource-Limited Settings. |
|
|
Nov 29, 2012 |
970 |
| Mylan Selected As One of the Leading Suppliers to the South African National Department of Health 2013/2014 Antiretroviral Tender. |
|
|
Nov 29, 2012 |
594 |
| Janssen Announces Intent Not to Enforce Patents for Darunavir in Resource-Limited Settings. |
|
|
Nov 29, 2012 |
992 |
| UNAIDS and Stop TB Join Forces against HIV/TB Deaths. |
|
|
Nov 28, 2012 |
718 |
| European Commission Approves Viread[R] for HIV-1 Infection in Children and Adolescents and for Chronic Hepatitis B in Adolescents. |
|
|
Nov 27, 2012 |
1272 |
| Chimerix To Present At Therapeutic Area Partnerships Meeting. |
|
|
Nov 26, 2012 |
474 |
| Austria,China : Marinomed Granted Chinese Patent for Antiviral Polymer. |
|
|
Nov 19, 2012 |
290 |
| Ligand Announces Positive Preclinical Data on HepDirect[TM] Liver-Targeted Antiviral for the Treatment of Hepatitis C. |
|
|
Nov 13, 2012 |
935 |
| Abbott Announces Phase 3 Hepatitis C Program Details. |
|
|
Nov 13, 2012 |
983 |
| Abbott Announces Phase 3 Hepatitis C Program Details. |
|
|
Nov 13, 2012 |
1006 |
| BioCryst Broad-Spectrum Antiviral BCX4430 Highly Effective against Yellow Fever in a Preclinical Disease Model. |
|
|
Nov 12, 2012 |
1274 |
| Chimerix To Present At Two Upcoming Healthcare Conferences In November. |
|
Conference news |
Nov 12, 2012 |
503 |
| SCYNEXIS' Oral SCY-635 Shows Potential as an Immune Acting Antiviral to Augment Current HCV Treatments. |
|
|
Nov 11, 2012 |
858 |
| 3-V Biosciences Presents Positive Preclinical Data on HCV Product Candidates Targeting FASN at the American Association for the Study of Liver Disease Annual Meeting 2012. |
|
|
Nov 10, 2012 |
812 |
| FDA Approves New 800mg PREZISTA (darunavir) Tablet. |
|
|
Nov 9, 2012 |
1936 |
| SCYNEXIS to Report Phase 2a Study of SCY-635 for Treatment of HCV at AASLD. |
|
|
Nov 6, 2012 |
616 |
| Early use of antiviral medications may help prevent lung failure in children with the flu. |
|
|
Nov 5, 2012 |
926 |
| Nevirapine for PMTCT in immuno-competent pregnant women--a warning. |
Seggie, Janet |
Brief article |
Nov 1, 2012 |
103 |
| Improving access and quality of care in a TB control programme. |
Scott, Vera; Azevedo, Virginia; Caldwell, Judy |
Report |
Nov 1, 2012 |
3453 |
| Safety of nevirapine in HIV-infected pregnant women initiating antiretroviral therapy at higher CD4 counts: A systematic review and meta-analysis. |
Bera, Ebrahim; Mia, Rafiq |
Report |
Nov 1, 2012 |
4701 |
| Pretreatment care predicts response to HCV therapy. |
Moon, Mary Ann |
|
Nov 1, 2012 |
509 |
| HCV patients given antivirals have less liver cancer. |
Napoli, Denise |
|
Nov 1, 2012 |
470 |
| BioCryst Provides Update Regarding BCX5191 Development Plan Following Discussion With FDA. |
|
|
Oct 30, 2012 |
1768 |
| Visterra presents prophylactic and therapeutic efficacy data of VIS410 against the H5N1 (Avian Flu) influenza strain in Hanoi, Viet Nam. |
|
|
Oct 29, 2012 |
981 |
| AHF: Gilead Scores Record Profits on AIDS Drug Price Gouging. |
|
Financial report |
Oct 25, 2012 |
677 |
| PREZISTA(R)(darunavir) Oral Suspension Receives European Commission Approval for Young Children With HIV-1 Infection. |
|
|
Oct 25, 2012 |
1371 |
| PREZISTA(R)(darunavir) Oral Suspension Receives European Commission Approval for Young Children With HIV-1 Infection. |
|
|
Oct 25, 2012 |
1376 |
| 2 paths used by Dengue virus to penetrate cells identified. |
|
Disease/Disorder overview |
Oct 24, 2012 |
372 |
| PTC Therapeutics Receives $1 Million Grant Award from the National Institutes of Health (NIH) to Support Research for a Treatment for Dengue Fever. |
|
|
Oct 22, 2012 |
715 |
| AiCuris and Merck Enter Exclusive Worldwide License Agreement for Investigational Portfolio Targeting Human Cytomegalovirus. |
|
|
Oct 15, 2012 |
1167 |
| Cruel Joke: AIDS-Plagued Tanzania Must Also Cope With Fake HIV Drugs. |
|
|
Oct 12, 2012 |
614 |
| Particle Sciences to Develop Antiretroviral Formulations as part of MOTIF. |
|
|
Oct 10, 2012 |
321 |
| Neutron Crystallography Aids Drug Design. |
|
|
Oct 9, 2012 |
599 |
| AHF: Texas and Louisiana Medicaid Not Yet Covering Gilead's Pricey AIDS Drug, Stribild. |
|
|
Oct 8, 2012 |
1136 |
| Anti-HIV Drug Could Be Repurposed To Fight Aggressive Breast Cancer. |
|
|
Oct 5, 2012 |
536 |
| PLOS ONE Study Finds HIV Genotypic Sequencing Test Performs Comparably to Standard Phenotypic Test in Predicting Potential Response to CCR5 Antagonist. |
|
Clinical report |
Oct 2, 2012 |
1200 |
| 3-V Biosciences To Present Data on HCV Product Candidates at the American Association for the Study of Liver Disease Annual Meeting 2012. |
|
|
Oct 1, 2012 |
499 |
| Challenges with using estimates when calculating ART need among adults in South Africa. |
Gerritsen, Annette A.M.; Mitchell, Janine S.; Johnson, Suzanne M.; Delva, Wim |
Report |
Oct 1, 2012 |
1534 |
| The impact of HIV infection on maternal deaths in South Africa. |
Chweneyagae, D.; Delis-Jarrosay, N.; Farina, Z.; Fawcus, S.; Godi, N.P.; Khaole, N.; Kunene, B.; Mhl |
|
Oct 1, 2012 |
5241 |
| SSSSHHHH... |
|
|
Sep 30, 2012 |
134 |
| HIV Drug Efavirenz May Cause Memory Decline. |
|
|
Sep 29, 2012 |
347 |
| Common HIV drug may damage brain and lead to memory decline. |
|
|
Sep 28, 2012 |
613 |
| MicroDose Therapeutx Announces Successful Conclusion of Safety Study in Asthmatic Patients for MDT-637 and Presentation of Overall Phase 1 Results at the 8th Annual International Respiratory Syncytial Virus (RSV) Symposium. |
|
|
Sep 28, 2012 |
667 |
| Research and Markets: Human Immunodeficiency Virus (HIV) (Event Driven). |
|
|
Sep 27, 2012 |
324 |
| AHF: Gilead's Stribild Not Covered by NY Medicaid; State Also Explores 'Prior Auth' Status for AIDS Drug. |
|
|
Sep 24, 2012 |
756 |
| Chimerix Presents Data Highlighting Burden Of Care Associated With Current Antiviral Therapies In Stem Cell Transplantation. |
|
|
Sep 21, 2012 |
1047 |
| Research and Markets: Global HIV Drug Pipeline Capsule - 2012 Update. |
|
|
Sep 19, 2012 |
293 |
| AHF: Gilead Must Offer ADAP AIDS Drug Price Cut to Medicaid, Medicare. |
|
|
Sep 18, 2012 |
1123 |
| Roche cytomegalovirus viral load test now available in US. |
|
|
Sep 17, 2012 |
853 |
| HIV treatment-naive option okayed. |
|
|
Sep 15, 2012 |
116 |
| Cost-effectiveness over five years. |
Ault, Alicia |
|
Sep 15, 2012 |
537 |
| United States : New Common Application for HIV/AIDS Medicines Available Through Johnson & Johnson Patient Assistance Foundation, Inc. |
|
|
Sep 13, 2012 |
383 |
| New Common Application for HIV/AIDS Medicines Available Through Johnson & Johnson Patient Assistance Foundation, Inc. |
|
|
Sep 12, 2012 |
548 |
| AstraZeneca And The Broad Institute Partner To Advance Discovery Of Antibacterial And Antiviral Agents. |
|
|
Sep 10, 2012 |
919 |
| Anti-HIV vaginal ring can prevent virus transmission. |
|
|
Sep 6, 2012 |
472 |
| Research and Markets: Antiviral Therapeutics - Technologies, Markets and Companies - 2012 Report. |
|
Report |
Sep 6, 2012 |
880 |
| AHF Supports Price Cut on New AIDS Drug, Prods Gilead to Expand Cut to Other Programs. |
|
|
Sep 6, 2012 |
994 |
| Medivir Acquires Preclinical Antiviral Programs Including Hepatitis C and Prodrug Technologies. |
|
|
Sep 5, 2012 |
431 |
| NanoViricides Reports that Oral Administration of FluCide[R] Anti-Influenza Drug Candidates Led to Strong Antiviral Antibody Response in a Highly Lethal Animal Model. |
|
|
Sep 4, 2012 |
1010 |
| Mylan Selected as a Leading ARV Supplier to India's National AIDS Control Organization. |
|
|
Sep 4, 2012 |
452 |
| New computer model offers 'realistic' tool to predict HIV drug resistance. |
|
|
Sep 3, 2012 |
415 |
| Comparing indirect fluorescent antibody assays to rapid diagnostic tests for the detection of influenza A(H11N1)pdm09. |
Okubo, Sandra; Cheung, Michele; Adler-Shohet, Felice C. |
|
Sep 1, 2012 |
2831 |
| Drug resistance can be managed, study finds. |
Currie, Donya |
|
Sep 1, 2012 |
230 |
| CDC outlines heterosexual HIV prophylaxis: from morbidity and mortality weekly report. |
Tucker, Miriam E. |
|
Sep 1, 2012 |
546 |
| Update: ARV dosing chart for children and adolescents, 2012. |
Nuttall, James; Schowalter, Laurie |
|
Sep 1, 2012 |
1196 |
| Estimated use of abacavir among adults and children enrolled in public sector antiretroviral therapy programmes in Gauteng Province, South Africa. |
Evans, Denise; Maskew, Mhairi; Heneger, Cassidy; Sanne, Ian |
Report |
Sep 1, 2012 |
3943 |
| TB/HIV integration at primary care level: a quantitative assessment at 3 clinics in Johannesburg, South Africa. |
Page-Shipp, L.; De Lima, Y. Voss; Clouse, K.; de Vos, J.; Evarts, L.; Bassett, J.; Sanne, I.; Van Ri |
Report |
Sep 1, 2012 |
4555 |
| Cervical intra-epithelial neoplasia in HIV-positive women after excision of the transformation zone--does the grade change? |
Kabir, Firdousi; van Gelderen, Cyril; McIntyre, James; Michelow, Pam; Turton, Dianne; Adam, Yasmin |
Report |
Sep 1, 2012 |
2948 |
| Recall of lost-to-follow-up pre-antiretroviral therapy patients in the Eastern Cape: Effect of mentoring on patient care. |
Jones, Martin; Stander, Maryna; van Zyl, Marlene; Cameron, David |
Report |
Sep 1, 2012 |
1886 |
| CDC outlines heterosexual HIV prophylaxis. |
Tucker, Miriam E. |
|
Sep 1, 2012 |
522 |
| HIV manifestations in the head and neck: the human immunodeficiency virus (HIV) and AIDS continue to create major changes in the practice of medicine. |
Hoek, Werner |
|
Sep 1, 2012 |
2196 |
| Starting HIV treatment reduces risk of tuberculosis, even for patients with higher CD4 cell counts. |
Carter, Michael |
|
Sep 1, 2012 |
639 |
| Almost 30% of US group in care for HIV don't use condoms regularly. |
|
|
Sep 1, 2012 |
1299 |
| Protease inhibitors and stomach acid drugs linked to fractures in HIV+ veterans. |
|
|
Sep 1, 2012 |
1443 |
| United States : 4-in-1 HIV combination pill approved by FDA. |
|
|
Aug 31, 2012 |
279 |
| Research and Markets: Lopinavir - Comprehensive Patent Search. |
|
|
Aug 31, 2012 |
446 |
| AHF to Take a Leading Role in HIV/AIDS Research. |
|
|
Aug 28, 2012 |
1931 |
| United States : FDA approves new combination pill for HIV treatment for some patients. |
|
|
Aug 28, 2012 |
414 |
| Novira Therapeutics Secures $23 Million Series A Financing to Advance Development of Antivirals for Treatment of Chronic Hepatitis B and HIV Infections. |
|
|
Aug 24, 2012 |
1058 |
| AHF: As Gilead Prepares to Price the 'Quad,' 20 California Legislators Say Aids Drug Pricing "Unsustainable". |
|
|
Aug 18, 2012 |
996 |
| The efficacy of Pelargonium sidoides in the treatment of upper respiratory tract infections in children with transient hypogammaglobulinemia of infancy. |
Patiroglu, Turkan; Tunc, Aydin; Gungor, Hatice Eke; Unal, Ekrem |
Clinical report |
Aug 15, 2012 |
3675 |
| AHF Lauds Rep. Alcee Hastings (D, FL) for Congressional Letter Cautioning Gilead on Pricing of New AIDS Drug. |
|
|
Aug 14, 2012 |
1483 |
| Ukraine : Still more HIV/AIDS patients will be provided with antiretroviral therapy. |
|
|
Aug 11, 2012 |
146 |
| Potent first-strike influenza drug target identified. |
|
|
Aug 4, 2012 |
825 |
| Ranbaxy, Gilead Sciences ink in-licensing pact to promote access to less costly HIV drugs. |
|
|
Aug 3, 2012 |
315 |
| Gilead Sciences Announces New Collaboration with Indian Partners to Reduce Manufacturing Cost and Improve Availability of Emtricitabine-Based Antiretroviral Therapy in Developing Countries. |
|
|
Aug 2, 2012 |
1425 |
| Target for potent first-strike influenza drugs identified. |
|
|
Aug 2, 2012 |
1298 |
| Profile of cause of death assigned to adults on antiretroviral therapy in Soweto. |
Karstaedt, A.S. |
Report |
Aug 1, 2012 |
2246 |
| Truvada approved for HIV prevention. |
|
|
Aug 1, 2012 |
333 |
| Start antiretrovirals regardless of CD4 counts. |
Napoli, Denise |
|
Aug 1, 2012 |
560 |
| SA patent law blocking vital second-line HIV drugs. |
Bateman, Chris |
|
Aug 1, 2012 |
354 |
| Rate of hospital admissions for AIDS falls, while heart disease rate climbs. |
|
|
Aug 1, 2012 |
2468 |
| Low vitamin D linked to coronary artery disease in blacks with HIV. |
|
|
Aug 1, 2012 |
1827 |
| HIV can be found in semen even when viral load is undetectable in blood. |
|
|
Aug 1, 2012 |
1269 |
| Good antidepressant pill-taking linked to better antiretroviral pill-taking. |
|
|
Aug 1, 2012 |
1799 |
| Prosetta Antiviral Inc Enters into Multi-year Antiviral Drug Development Collaboration with Bristol-Myers Squibb. |
|
|
Jul 31, 2012 |
329 |
| Early HIV treatment offers additional benefits. |
|
Clinical report |
Jul 28, 2012 |
429 |
| United Kingdom,United States : Once-daily dolutegravir is non-inferior to twice-daily raltegravir in treatment-naE[macron]ve adults with HIV-1. |
|
|
Jul 27, 2012 |
364 |
| United States : MERCK inks two licensing agreements for HIV drug candidates. |
|
|
Jul 27, 2012 |
155 |
| Expanded Analysis of HPTN 052 Study Results Show Cost-Effectiveness of Early Treatment of HIV. |
|
Conference news |
Jul 27, 2012 |
839 |
| Once-Daily Dolutegravir is Non-Inferior to Twice-Daily Raltegravir in Treatment-Naive Adults with HIV-1. |
|
|
Jul 26, 2012 |
1938 |
| Once-Daily Dolutegravir is Non-Inferior to Twice-Daily Raltegravir in Treatment-Naive Adults with HIV-1. |
|
|
Jul 26, 2012 |
1979 |
| AIDS cure may have two main pathways: experts. |
|
|
Jul 25, 2012 |
797 |
| Gilead's HIV Integrase Inhibitor Elvitegravir Dosed Once Daily as Effective as Twice-Daily Raltegravir Over Two Years of Therapy in Pivotal Phase 3 Study. |
|
|
Jul 24, 2012 |
1472 |
| Gilead's Boosting Agent Cobicistat for HIV Therapy as Effective as Ritonavir in Pivotal Phase 3 Study. |
|
Clinical report |
Jul 24, 2012 |
1639 |
| Many HIV-infected patients taking ART fail to keep disease in check. |
|
|
Jul 23, 2012 |
769 |
| Ending global HIV/AIDS pandemic is within our reach. |
|
|
Jul 23, 2012 |
479 |
| Anti-HIV drugs 'may pass to baby in womb and during breast-feeding'. |
|
|
Jul 22, 2012 |
682 |
| WHO issues HIV medication guidance. |
|
|
Jul 22, 2012 |
479 |
| Marine sponge shows promise for new class of HIV anti-viral drugs. |
|
|
Jul 20, 2012 |
533 |
| Obama Administration Touts Delayed Release of AIDS Drug Funds, Says AHF. |
|
|
Jul 19, 2012 |
452 |
| HarborPath Creates a Single Portal for Uninsured Individuals to Access HIV/AIDS Medications. |
|
|
Jul 19, 2012 |
1207 |
| WHO urges 'strategic use' of HIV medicines. |
|
|
Jul 18, 2012 |
808 |
| U.S. Food and Drug Administration Approves Gilead's Truvada[R] for Reducing the Risk of Acquiring HIV. |
|
|
Jul 16, 2012 |
2127 |
| AVAC Welcomes Landmark FDA Approval of (Truvada) TDF/FTC as PrEP for HIV - Urges Immediate Steps to Make Important New HIV Prevention Option Available for the Men and Women Who Need It. |
|
|
Jul 16, 2012 |
1264 |
| Research and Markets: Generics in the Antivirals Market to 2018 - Launch of Generic Combivir and Patent Expiry of Sustiva, Kaletra and Epivir-HBV will Drive Volume Growth. |
|
|
Jul 12, 2012 |
366 |
| Chimerix Announces BK Virus Data In Late-Breaking Poster Session At The 24th International Congress Of The Transplantation Society. |
|
|
Jul 9, 2012 |
621 |
| AHF: Gilead's "Me Too" Quad AIDS Drug Offers Little Improvement, More Kidney Damage. |
|
|
Jul 6, 2012 |
1276 |
| Roche receives FDA approval for Cytomegalovirus viral load test. |
|
|
Jul 5, 2012 |
834 |
| Benchtop flow cytometry, helps monitor HIV in sub-Saharan Africa. |
Mulry, Jim |
Report |
Jul 1, 2012 |
1371 |
| World Health Organization sets out route map for scale-up of treatment as prevention. |
Alcorn, Keith |
|
Jul 1, 2012 |
990 |
| First nurses trained to initiate MDR-TB treatment. |
Bateman, Chris |
|
Jul 1, 2012 |
358 |
| Gilead Submits New Drug Application to U.S. FDA for Boosting Agent Cobicistat. |
|
|
Jun 28, 2012 |
775 |
| AHF: CA State Treasurer Lockyer Urges Gilead to Show Restraint Pricing New AIDS Drug the 'Quad'. |
|
|
Jun 27, 2012 |
930 |
| When and why the South African government disobeys Constitutional Court orders. |
Hausman, David |
|
Jun 22, 2012 |
8665 |
| Adding nevirapine to HIV regimen halves newborn transmission rate. |
|
Brief article |
Jun 21, 2012 |
105 |
| AHF Delegation to Geneva Alerts Health Officials About Dire Situation Regarding Access to HIV Treatment in Ukraine. |
|
|
Jun 13, 2012 |
494 |
| Ohio: AIDS Patients Win Another Round against State's Illegal Restrictions on AIDS Drug Access, Says AHF. |
|
|
Jun 12, 2012 |
1163 |
| AIDS Advocates to Gilead: Save More Lives, Price the "Quad" Reasonably. |
|
|
Jun 11, 2012 |
1199 |
| Enamine, MRC LMB and IOCB Announce Collaboration to Identify Novel Rhomboid Protease Inhibitors for Treatment of Various Diseases. |
|
|
Jun 6, 2012 |
506 |
| One Year Post-Launch, The Protease Inhibitors, Incivek and Victrelis have Collectively Penetrated Over Three-Quarters of the US Genotype 1 HCV Market. |
|
|
Jun 6, 2012 |
786 |
| Mylan Launches Generic Version of Epivir Film Coated Tablets in the UK and Italy, its First Generic ARV Launch in Europe. |
|
|
Jun 6, 2012 |
452 |
| Mylan Launches Generic Version of Epivir Film Coated Tablets in the UK and Italy, its First Generic ARV Launch in Europe. |
|
|
Jun 6, 2012 |
400 |
| Cannabis Science Initiates HIV TAT Anti-Viral Drug Development Program; CS-TATI-1 Lead Hit Discovery Commenced for Pre-Clinical Proof of Concept Development. |
|
|
Jun 5, 2012 |
938 |
| Delaware Chancery Court Issues Final Order And Judgment Upholding Its Favorable Ruling. |
|
|
Jun 1, 2012 |
1402 |
| Delay in commencing treatment for MDR TB at a specialised TB treatment centre in KwaZulu-Natal. |
Narasimooloo, R.; Ross, A. |
Report |
Jun 1, 2012 |
2401 |
| Haematological complications of HIV infection. |
Opie, Jessica |
Report |
Jun 1, 2012 |
3173 |
| Herpetic ulcer of the eyelids in an immunocompromised patient. |
du Toit, Nagib; van der Merwe, Junet |
Case study |
Jun 1, 2012 |
850 |
| The complexity of HIV vasculopathy. |
Stanley, Alan; Candy, Sally; Levin, Candyce; Heckmann, Jeannine M. |
Case study |
Jun 1, 2012 |
1851 |
| Renal transplantation between HIV-positive donors and recipients justified. |
Muller, Elmi; Barday, Zunaid; Mendelson, Marc; Kahn, Delawir |
Report |
Jun 1, 2012 |
1529 |
| The prevalence and burden of pain and other symptoms among South Africans attending HAART clinics. |
Farrant, Lindsay; Gwyther, Liz; Dinat, Natalya; Mmoledi, Keletso; Hatta, Ntombi; Harding, Richard |
Report |
Jun 1, 2012 |
1781 |
| Remote sensing of HIV care programmes using centrally collected laboratory results: can we monitor ART programme effectiveness? |
Morrow, Carl; Munro, Alison; Wilke, Marisa; Stark, Ruth; Wood, Robin |
Report |
Jun 1, 2012 |
3930 |
| Burden of antituberculosis and antiretroviral drug-induced liver injury at a secondary hospital in South Africa. |
Schutz, Charlotte; Ismail, Zahiera; Proxenos, Charles John; Marais, Suzaan; Burton, Rosie; Kenyon, C |
Report |
Jun 1, 2012 |
4366 |
| Immunological characterisation of an unmasking TB-IRIS case. |
Wilkinson, Katalin A.; Meintjes, Graeme; Seldon, Ronnett; Goliath, Rene; Wilkinson, Robert J. |
Report |
Jun 1, 2012 |
4245 |
| The role of the Infectious Diseases Unit at Groote Schuur Hospital in addressing South Africa's greatest burden of disease. |
Pandie, Mishal; van der Plas, Helen; Maartens, Gary; Mendelson, Marc |
Report |
Jun 1, 2012 |
2927 |
| Message from the executive. |
Conradie, Francesca |
|
Jun 1, 2012 |
580 |
| Approaches to tenofovir and abacavir drug shortages in South Africa: a guide for clinicians. |
Schowalter, Laurie; Conradie, Francesca |
|
Jun 1, 2012 |
816 |
| Inter-and intra-laboratory variability of CD4 cell counts in Swaziland. |
Mlawanda, Ganizani; Rheeder, Paul; Miot, Jacqui |
Report |
Jun 1, 2012 |
3926 |
| Localised treatment and 6-month outcomes in patients with cytomegalovirus retinitis at a tertiary ophthalmology service in Ga-Rankuwa. |
Laher, Fatima; Cullen, Claire; Matlala, J. Baile |
Report |
Jun 1, 2012 |
2598 |
| Implementation of the new WHO recommendations on HIV and infant feeding: challenges and the way forward. |
Sagoe-Moses, C.; Mwinga, K.; Habimana, P.; Toure, I.D.; Ketsela, T. |
Report |
Jun 1, 2012 |
7663 |
| Blips and its clinical relevance in HIV patients on treatment. |
Khan, Matin Ahmad |
Report |
Jun 1, 2012 |
8369 |
| Has a time to talk about cure of AIDS arrived? |
Khan, Matin Ahmad |
Report |
Jun 1, 2012 |
11776 |
| Why swine flu virus develops drug resistance. |
|
|
May 30, 2012 |
370 |
| New protein may fight flu outbreak. |
|
|
May 28, 2012 |
296 |
| Gilead Files European Marketing Application for Boosting Agent Cobicistat. |
|
|
May 23, 2012 |
809 |
| Mylan Launches Generic Version of Viramune Tablets. |
|
|
May 23, 2012 |
468 |
| Since Gaining European Authority Approval for Victrelis in July and Incivo in September, Protease Inhibitor Share Has Penetrated Nearly One-Third of the Genotype 1 Market and is Anticipated to Significantly Increase Over the Next Six Months. |
|
|
May 21, 2012 |
690 |
| FDA Approves New Labeling for ISENTRESS[R] (raltegravir) to Include 156-Week Data Demonstrating Long-Term Efficacy, Safety and Tolerability with ISENTRESS in Combination Therapy in Previously Untreated Adult Patients Infected with HIV-1. |
|
|
May 21, 2012 |
2398 |
| Anti-HIV drug tenofovir 'safe to take during pregnancy'. |
|
Medical condition overview |
May 16, 2012 |
428 |
| 'Switch' that boosts 'innate immunity' to ward off infectious diseases discovered. |
|
|
May 12, 2012 |
481 |
| FDA Advisory Committee Supports Approval of Gilead's Truvada[R] for Reducing the Risk of Acquiring HIV. |
|
|
May 11, 2012 |
982 |
| FDA Advisory Committee Supports Approval of Gilead's Once-Daily Quad Single Tablet Regimen for HIV. |
|
|
May 11, 2012 |
941 |
| University of Washington, University of Texas Medical Branch and Kineta, Inc. Granted $8.1 Million for Biodefense Antiviral Drug Development. |
|
|
May 8, 2012 |
1293 |
| Research and Markets: Hepatitis C Virus - Protease Inhibitors Bring Change in the Treatment Paradigm for Hepatitis C Virus Infection - What Next? |
|
|
May 3, 2012 |
375 |
| Anti-HIV drug use during pregnancy does not affect infant size, birth weight. |
|
|
May 1, 2012 |
124 |
| Antiretrovirals may help prevent HIV. |
Currie, Donya |
|
May 1, 2012 |
208 |
| Data support early treatment. |
|
Brief article |
May 1, 2012 |
229 |
| Immunel supports immune modulation. |
|
Clinical report |
May 1, 2012 |
161 |
| ARV factory welcomed. |
|
|
May 1, 2012 |
244 |
| Prevention of mother-to-child HIV transmission a long way off in DR Congo. |
|
Brief article |
May 1, 2012 |
173 |
| Research and Markets: Antivirals Market to 2017 - Increased Uptake of High Priced Combination Drugs will Offset the Impact of Generics in the HIV Therapeutics Market. |
|
|
Apr 30, 2012 |
400 |
| MicroDose Therapeutx Announces Conclusion of MDT-637 Phase I Single and Multiple Ascending Dose Studies in Healthy Volunteers for Treatment of Respiratory Syncytial Virus (RSV). |
|
|
Apr 24, 2012 |
606 |
| Regulus Receives Allowance from Japan and U.S. Patent Offices for HCV Intellectual Property, Expanding Leading Worldwide Patent Estate. |
|
|
Apr 23, 2012 |
1382 |
| Santaris Pharma A/S presents final Phase 2a study results for miravirsen showing dose-dependent, prolonged antiviral activity in Hepatitis C patients. |
|
Clinical report |
Apr 19, 2012 |
2053 |
| All-Oral Hepatitis C Virus Treatment with Bristol-Myers Squibb's Investigational Compounds Daclatasvir and Asunaprevir Achieved Sustained Virologic Response in 77% of Difficult-to-Treat Patients. |
|
|
Apr 19, 2012 |
1329 |
| Gilead Sciences to Present New Hepatitis B and C Data at European Conference on Liver Disease This Week. |
|
Conference news |
Apr 18, 2012 |
1735 |
| Vertex Advances INCIVEK[TM] (telaprevir) and Broad Portfolio of Medicines in Development With Goal of Further Expanding and Improving Treatment for People With Hepatitis C. |
|
|
Apr 18, 2012 |
3267 |
| Medivir Announces TMC435 in an Expanded Clinical Collaboration. |
|
|
Apr 18, 2012 |
1101 |
| Medivir Announces TMC435 in an Expanded Clinical Collaboration. |
|
|
Apr 18, 2012 |
1097 |
| AMRI Announces Development and Manufacturing Deal with Biota Holdings Limited. |
|
|
Apr 17, 2012 |
1001 |
| Antiretroviral switch linked to drop in BMD. |
London, Susan |
|
Apr 15, 2012 |
528 |
| San Francisco sees favorable trend in early ART initiation. |
London, Susan |
|
Apr 15, 2012 |
566 |
| Neuropsychological impairment detected early in HIV. |
London, Susan |
Clinical report |
Apr 15, 2012 |
673 |
| AHF: AIDS Patients Protest, Testify Against Ohio Plan to Ration AIDS Drugs. |
|
|
Apr 5, 2012 |
1112 |
| Chimerix to Present at Upcoming Needham and Future Leaders Conferences. |
|
Conference news |
Apr 3, 2012 |
737 |
| Shionogi-ViiV Healthcare Announces Initial Data from Pivotal Phase III Study of Dolutegravir in HIV. |
|
|
Apr 2, 2012 |
1604 |
| Impact of starting CD4 count, virologic failure, and treatment interruption on CD4 gains. |
|
|
Apr 1, 2012 |
1898 |
| Years of antiretroviral therapy do not raise risk of non-AIDS death. |
|
|
Apr 1, 2012 |
1625 |
| Preventable causes of death not rare in Seattle-area HIV group. |
|
|
Apr 1, 2012 |
1535 |
| Heart disease signals get worse with time in adults with HIV. |
|
|
Apr 1, 2012 |
2315 |
| Higher bone fracture risk in people with HIV or with HIV and HCV. |
|
|
Apr 1, 2012 |
2146 |
| Tuberculosis screening before anti-hepatitis C virus therapy in prisons. |
Babudieri, Sergio; Soddu, Andrea; Murino, Monica; Molicotti, Paola; Muredda, Alberto A.; Madeddu, Gi |
Case study |
Apr 1, 2012 |
1366 |
| Acceptability, feasibility and impact of routine screening to detect undiagnosed HIV infection in 17-24-month-old children in the western sub-district of Cape Town. |
Levin, Michael; Mathema, Hlengani; Stinson, Kathryn; Jennings, Karen |
Report |
Apr 1, 2012 |
3440 |
| Some prescription drugs inhibit 17P metabolism. |
Worcester, Sharon |
|
Apr 1, 2012 |
772 |
| Effect of Moringa oleifera Lam. leaves powder on the evolution of hemogram profile in togolese undernourished children: evaluation on HIV-positive patients/ Effet de la poudre de feuilles de Moringa oleifera Lam. sur l'evolution du profil de l'hemogramme des enfants malnutris au togo: evaluation chez les sujets HIV positifs. |
Tete-Benissan, A.; Lawson-Evi, K.A.; Kokou, K.; Gbeassor, M. |
Report |
Apr 1, 2012 |
7730 |
| Efavirenz-induced psychosis: a case study. |
Galbraith, Nicola |
Case study |
Mar 22, 2012 |
1791 |
| Antiretroviral treatment as prevention: considerations for nursing practice. |
Bennett, Juliet |
Report |
Mar 22, 2012 |
2601 |
| Cancer cells send out alarm to warn against tumour-killing virus. |
|
|
Mar 16, 2012 |
457 |
| Getting HIV-positive set into care challenging. |
London, Susan |
Survey |
Mar 15, 2012 |
801 |
| Data Show Gilead's Quad Regimen for HIV Non-Inferior to Protease-Based Regimen at 48 Weeks in Second Pivotal Phase 3 Study. |
|
Clinical report |
Mar 9, 2012 |
1674 |
| PharmAthene Reports Year-End 2011 Financial and Operational Results. |
|
|
Mar 8, 2012 |
6427 |
| Gilead's Quad Single Tablet Regimen for HIV Non-Inferior to Atripla[R] in Pivotal Phase 3 Study. |
|
|
Mar 7, 2012 |
1632 |
| Chimerix to Present at Cowen and Company's 32nd Annual Health Care Conference. |
|
Conference news |
Mar 5, 2012 |
713 |
| False-positive HIV DNA PCR testing of infants: implications in a changing epidemic. (Original Articles). |
Feucht, Ute; Forsyth, Brian; Kruger, Mariana |
Report |
Mar 1, 2012 |
4002 |
